Sotera Health Company (SHC)
SHC Stock Price Chart
Explore Sotera Health Company interactive price chart. Choose custom timeframes to analyze SHC price movements and trends.
SHC Company Profile
Discover essential business fundamentals and corporate details for Sotera Health Company (SHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
20 Nov 2020
Employees
3.00k
Website
https://soterahealth.comCEO
Michael Petras Jr.
Description
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
SHC Financial Timeline
Browse a chronological timeline of Sotera Health Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.24, while revenue estimate is $309.70m.
Earnings released on 5 May 2026
EPS came in at $0.18 surpassing the estimated $0.17 by +5.88%, while revenue for the quarter reached $280.05m , beating expectations by +3.42%.
Earnings released on 24 Feb 2026
EPS came in at $0.26 surpassing the estimated $0.24 by +8.33%, while revenue for the quarter reached $303.44m , beating expectations by +1.32%.
Earnings released on 4 Nov 2025
EPS came in at $0.26 surpassing the estimated $0.22 by +18.18%, while revenue for the quarter reached $311.31m , beating expectations by +3.92%.
Earnings released on 8 Aug 2025
EPS came in at $0.20 surpassing the estimated $0.17 by +17.65%, while revenue for the quarter reached $294.34m , missing expectations by -3.49%.
Earnings released on 1 May 2025
EPS came in at $0.14 surpassing the estimated $0.12 by +16.67%, while revenue for the quarter reached $254.52m , missing expectations by -8.10%.
Earnings released on 27 Feb 2025
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $290.20m , beating expectations by +11.75%.
Earnings released on 5 Nov 2024
EPS came in at $0.17 falling short of the estimated $0.19 by -10.53%, while revenue for the quarter reached $285.47m , missing expectations by -2.18%.
Earnings released on 5 Aug 2024
EPS came in at $0.19 surpassing the estimated $0.17 by +11.76%, while revenue for the quarter reached $276.59m , beating expectations by +3.81%.
Earnings released on 2 May 2024
EPS came in at $0.13 falling short of the estimated $0.14 by -7.14%, while revenue for the quarter reached $248.18m , beating expectations by +1.48%.
Earnings released on 27 Feb 2024
EPS came in at $0.26 matching the estimated $0.26, while revenue for the quarter reached $310.24m , beating expectations by +2.68%.
Earnings released on 1 Nov 2023
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $263.18m , missing expectations by -12.00%.
Earnings released on 3 Aug 2023
EPS came in at $0.21 surpassing the estimated $0.18 by +16.67%, while revenue for the quarter reached $255.28m , missing expectations by -1.41%.
Earnings released on 3 May 2023
EPS came in at $0.13 falling short of the estimated $0.14 by -7.14%, while revenue for the quarter reached $220.59m , missing expectations by -0.20%.
Earnings released on 28 Feb 2023
EPS came in at $0.25 surpassing the estimated $0.22 by +13.64%, while revenue for the quarter reached $251.59m , beating expectations by +1.67%.
Earnings released on 2 Nov 2022
EPS came in at $0.23 surpassing the estimated $0.22 by +4.55%, while revenue for the quarter reached $248.70m , beating expectations by +0.20%.
Earnings released on 4 Aug 2022
EPS came in at $0.27 surpassing the estimated $0.24 by +12.50%, while revenue for the quarter reached $266.64m , beating expectations by +4.03%.
Earnings released on 5 May 2022
EPS came in at $0.22 surpassing the estimated $0.19 by +15.79%, while revenue for the quarter reached $236.75m , beating expectations by +2.86%.
Earnings released on 1 Mar 2022
EPS came in at $0.23 surpassing the estimated $0.22 by +4.55%, while revenue for the quarter reached $241.25m , beating expectations by +2.06%.
Earnings released on 10 Nov 2021
EPS came in at $0.21 surpassing the estimated $0.20 by +5.00%, while revenue for the quarter reached $226.16m , beating expectations by +5.56%.
Earnings released on 12 Aug 2021
EPS came in at $0.26 surpassing the estimated $0.21 by +23.81%, while revenue for the quarter reached $251.92m , meeting expectations.
SHC Stock Performance
Access detailed SHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
